LEADER 01848nam 2200529 a 450 001 9910780312003321 005 20240208151141.0 010 $a1-282-08400-3 010 $a9786612084003 010 $a0-309-52962-X 035 $a(CKB)111090425020476 035 $a(OCoLC)55636758 035 $a(CaPaEBR)ebrary10055047 035 $a(SSID)ssj0000336717 035 $a(PQKBManifestationID)12099905 035 $a(PQKBTitleCode)TC0000336717 035 $a(PQKBWorkID)10282252 035 $a(PQKB)10489191 035 $a(MiAaPQ)EBC3376053 035 $a(EXLCZ)99111090425020476 100 $a20150424d2002 uy| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDietary Reference Intakes$b[electronic resource] $eguiding principles for nutrition labeling and fortification /$fInstitute of Medicine (US) Committee on Use of Dietary Reference Intakes in Nutrition Labeling /$fCommittee on Use of Dietary Reference Intakes in Nutrition Labeling, Food and Nutrition Board 210 $aWashington, DC, USA $cNational Academies Press$d2002 210 $cNational Academies Press 215 $a1 online resource (224 pages) 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a0-309-09143-8 606 $aNutrition 606 $aNutrition$xLabeling 606 $aDietary reference intakes 606 $aMEDICAL$2bisac 615 0$aNutrition. 615 0$aNutrition$xLabeling. 615 0$aDietary reference intakes. 615 7$aMEDICAL 700 $aCommittee on Use of Dietary Reference Intakes in Nutrition Labeling$01574669 801 0$bPQKB 801 2$bAzTeS 906 $aBOOK 912 $a9910780312003321 996 $aDietary Reference Intakes$93851076 997 $aUNINA LEADER 05558nam 2200793Ia 450 001 9910969214503321 005 20200520144314.0 010 $a9781040171318 010 $a1040171311 010 $a9780429145803 010 $a0429145802 010 $a9781420044362 010 $a1420044362 024 7 $a10.3109/9781420044362 035 $a(CKB)2440000000014927 035 $a(EBL)1398233 035 $a(Au-PeEL)EBL1398233 035 $a(CaPaEBR)ebr10231547 035 $a(CaONFJC)MIL741358 035 $a(OCoLC)905983838 035 $a(OCoLC)892787778 035 $a(OCoLC)1289517935 035 $a(FINmELB)ELB152021 035 $a(Au-PeEL)EBL31892802 035 $a(MiAaPQ)EBC1398233 035 $a(MiAaPQ)EBC31892802 035 $a(OCoLC)1496390994 035 $a(EXLCZ)992440000000014927 100 $a20071115d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aModified-release drug delivery technology$hVolume 1 /$fedited by Michael J. Rathbone ... [et al.] 205 $a2nd ed. 210 $aNew York $cInforma Healthcare$dc2008 215 $a1 online resource (514 p.) 225 1 $aDrugs and the pharmaceutical sciences ;$v183 300 $aDescription based upon print version of record. 311 08$a9781336100725 311 08$a1336100729 311 08$a9781420044355 311 08$a1420044354 320 $aIncludes bibliographical references and indexes. 327 $aFront Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum 327 $aChapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex) 327 $aChapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract 327 $aChapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology 327 $aChapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover 330 $aThis two volume Second Edition describes the anatomical, physiological, pharmaceutical, and technological aspects of delivery routes, found in areas like:Oral Ocular Dermal and transdermal VaginalColonic Oral mucosal Nasal PulmonaryProviding insight and critical assessment of the many available and emerging modified release drug delivery systems for their current and future value, topics include:Intellectual property rights and regulatory issues and challengesosmotic systems and Qtrol. Qdis. Matrix Systemsthiolated polymers for CR, Oradur. IDD technology, and chronotherapy technologyOral-lynTM 410 0$aDrugs and the pharmaceutical sciences ;$v183. 606 $aControlled release technology 606 $aControlled release preparations 606 $aDrug delivery systems 606 $aPharmaceutical technology 615 0$aControlled release technology. 615 0$aControlled release preparations. 615 0$aDrug delivery systems. 615 0$aPharmaceutical technology. 676 $a615.19 701 $aRathbone$b Michael J.$f1957-$0318416 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910969214503321 996 $aModified-release drug delivery technology$94324346 997 $aUNINA